WIN-35428 WIN35428 CAS: 50370-56-4

CAS NO: 50370-56-4
Our products are for scientific research use only
WIN-35428 WIN35428
Chemical Name: (-)-2-BETA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)TROPANE
Molecular Formula: C16H20FNO2
Formula Weight: 277.33
CAS No.: 50370-56-4
Description Review
Description
Our products are for scientific research use only

WIN-35428, also known as CFT, is a synthetic stimulant drug belonging to the class of phenyltropanes. It is created by modifying the chemical structure of cocaine to reduce its addictive properties. It has the chemical name (−)-2β-Carbomethoxy-3β-(4-fluorophenyl)tropane, and the molecular formula C16H19NO2F. The molecular weight of WIN-35428 is 281.33 g/mol, and the CAS number is 50370-56-4.

Top Searched Keywords on Google and Synonyms on Google:

The top searched keywords on Google for WIN-35428 are "CFT effects," "WIN-35428 dosage," "CFT experience," and "CFT mechanism of action." Synonyms for WIN-35428 include 2β-Carbomethoxy-3β-(4-fluorophenyl)tropane, WIN35428, and 2-carbomethoxy-3-(4-fluorophenyl)tropane.

Health Benefits:

WIN-35428 has no known health benefits, as it is not approved for medical use.

Potential Effects:

WIN-35428 is a stimulant drug that affects the central nervous system. It has been shown to have similar effects to cocaine, including feelings of euphoria, increased energy, and decreased appetite. However, it is also much less addictive than cocaine, and has been studied as a potential treatment for cocaine addiction. Other potential effects of WIN-35428 include improved focus and concentration and mild to moderate pain relief.

Mechanisms:

WIN-35428 works by inhibiting the reuptake of the neurotransmitters dopamine, norepinephrine, and serotonin in the brain. This leads to an increase in the amount of these neurotransmitters in the synaptic cleft, resulting in an amplification of their effects on the central nervous system. By reducing the amount of cocaine that crosses the blood-brain barrier, it can reduce the rewarding effects of cocaine and make it less addictive.

Safety:

The safety of WIN-35428 has not been extensively studied, but it is generally considered to be safe when used at therapeutic doses. However, like all stimulant drugs, WIN-35428 can cause side effects such as high blood pressure, heart rate, and body temperature, as well as anxiety, paranoia, and insomnia. It should only be used under the supervision of a medical professional, and those who are pregnant or have a history of heart disease, high blood pressure, or epilepsy should not use the drug.

Side-Effects:

The side effects of WIN-35428 can vary depending on the dose and individual. The most common side effects are related to its CNS stimulant properties, and may include insomnia, anxiety, and paranoia. Other potential side effects include an increase in blood pressure and heart rate, as well as gastrointestinal problems such as nausea, diarrhea, and vomiting. Long-term use of WIN-35428 may also lead to addiction.

Dosage information:

The effective and safe dosage of WIN-35428 has not been established, as it is not approved for medical use. However, in studies, doses of up to 20-30 mg have been used without significant adverse effects. Those who choose to use WIN-35428 should start with a low dose and gradually increase it as needed, under the supervision of a medical professional. It is important to use caution and follow dosage instructions carefully to minimize the risk of side effects.

In conclusion, WIN-35428 is a synthetic stimulant drug that is used primarily as a research tool in studies of cocaine addiction. Though it has shown promise in reducing the rewarding effects of cocaine, its safety and effectiveness for this purpose have not been established. Like all CNS stimulants, it has potential for abuse and can cause a range of side effects, which can be minimized by using it under the guidance of a medical professional. Finally, WIN-35428 is not approved for medical use, and it should not be used for recreational purposes.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code